FI925053A7 - Imidatso(4,5-c)pyridiinejä, joilla on PAF-antagonistinen aktiivisuus - Google Patents

Imidatso(4,5-c)pyridiinejä, joilla on PAF-antagonistinen aktiivisuus Download PDF

Info

Publication number
FI925053A7
FI925053A7 FI925053A FI925053A FI925053A7 FI 925053 A7 FI925053 A7 FI 925053A7 FI 925053 A FI925053 A FI 925053A FI 925053 A FI925053 A FI 925053A FI 925053 A7 FI925053 A7 FI 925053A7
Authority
FI
Finland
Prior art keywords
pyridines
imidazo
antagonistic activity
paf antagonistic
paf
Prior art date
Application number
FI925053A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI925053L (fi
FI925053A0 (fi
Inventor
Anthony Marfat
James Frederick Eggler
Kelvin Cooper
Michael Jonathan Fray
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI925053L publication Critical patent/FI925053L/fi
Publication of FI925053A0 publication Critical patent/FI925053A0/fi
Publication of FI925053A7 publication Critical patent/FI925053A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI925053A 1990-05-09 1991-05-01 Imidatso(4,5-c)pyridiinejä, joilla on PAF-antagonistinen aktiivisuus FI925053A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52119990A 1990-05-09 1990-05-09
PCT/US1991/002997 WO1991017163A1 (en) 1990-05-09 1991-05-01 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY

Publications (3)

Publication Number Publication Date
FI925053L FI925053L (fi) 1992-11-06
FI925053A0 FI925053A0 (fi) 1992-11-06
FI925053A7 true FI925053A7 (fi) 1992-11-06

Family

ID=24075786

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925053A FI925053A7 (fi) 1990-05-09 1991-05-01 Imidatso(4,5-c)pyridiinejä, joilla on PAF-antagonistinen aktiivisuus

Country Status (28)

Country Link
EP (1) EP0533695B1 (enExample)
JP (1) JPH0678340B2 (enExample)
CN (1) CN1057839A (enExample)
AP (1) AP224A (enExample)
AT (1) ATE112567T1 (enExample)
AU (1) AU642265B2 (enExample)
BG (1) BG97059A (enExample)
BR (1) BR9106433A (enExample)
CA (1) CA2080476A1 (enExample)
DE (1) DE69104481T2 (enExample)
DK (1) DK0533695T3 (enExample)
ES (1) ES2061247T3 (enExample)
FI (1) FI925053A7 (enExample)
GT (1) GT199100031A (enExample)
HU (1) HUT62894A (enExample)
IE (1) IE911553A1 (enExample)
IL (1) IL98075A0 (enExample)
MA (1) MA22151A1 (enExample)
MY (1) MY105512A (enExample)
NO (1) NO924290D0 (enExample)
NZ (1) NZ238089A (enExample)
PE (1) PE26691A1 (enExample)
PT (1) PT97616A (enExample)
RO (1) RO109450B1 (enExample)
TW (1) TW205549B (enExample)
WO (1) WO1991017163A1 (enExample)
YU (1) YU81191A (enExample)
ZA (1) ZA913497B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
AU5016793A (en) * 1992-08-20 1994-03-15 Cytomed, Inc Dual functional anti-inflammatory and immunosuppressive agents
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
EP1077967B1 (en) * 1998-05-12 2002-12-04 Wyeth Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
WO2015039036A2 (en) 2013-09-13 2015-03-19 Cortendo Ab(Publ) Novel cytochrome p450 inhibitors and their method of use
CN105348182B (zh) * 2014-08-24 2018-04-13 复旦大学 2‑烷氧基苯甲酰芳胺类化合物及其药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8401486A1 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8822170D0 (en) * 1988-09-21 1988-10-26 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
HU9203496D0 (en) 1993-01-28
AP224A (en) 1992-10-27
EP0533695A1 (en) 1993-03-31
WO1991017163A1 (en) 1991-11-14
PE26691A1 (es) 1991-10-21
MY105512A (en) 1994-10-31
CA2080476A1 (en) 1991-11-10
EP0533695B1 (en) 1994-10-05
NO924290L (no) 1992-11-06
BG97059A (bg) 1993-12-24
FI925053L (fi) 1992-11-06
ATE112567T1 (de) 1994-10-15
YU81191A (sh) 1994-06-10
AU642265B2 (en) 1993-10-14
BR9106433A (pt) 1993-05-04
CN1057839A (zh) 1992-01-15
RO109450B1 (ro) 1995-02-28
DE69104481D1 (de) 1994-11-10
IE911553A1 (en) 1991-11-20
AP9100259A0 (en) 1991-07-31
AU7867191A (en) 1991-11-27
NZ238089A (en) 1992-10-28
GT199100031A (es) 1992-10-30
FI925053A0 (fi) 1992-11-06
JPH0678340B2 (ja) 1994-10-05
DE69104481T2 (de) 1995-02-09
NO924290D0 (no) 1992-11-06
IL98075A0 (en) 1992-06-21
TW205549B (enExample) 1993-05-11
MA22151A1 (fr) 1991-12-31
PT97616A (pt) 1992-03-31
DK0533695T3 (da) 1995-01-09
JPH05505619A (ja) 1993-08-19
ZA913497B (en) 1992-12-30
HUT62894A (en) 1993-06-28
ES2061247T3 (es) 1994-12-01

Similar Documents

Publication Publication Date Title
OA07130A (fr) Nouvelles imidazo[1,2-a]pyridines et pyridazines .
MX9202838A (es) Imidazo[1,5-a]quinoxalinas.
DE3888039D1 (de) Mehrzweck-Handkarren.
FI843001A7 (fi) Pyrrolo(1,2-a)imidazol- och imidatzo (1,2-a)pyridinimmunomodulatorer.
FI861262A7 (fi) 5- 5-(6-imidazo(1,2-a)pyridyl)pyridinderivativ.
FI961564A7 (fi) Imidatso(1,2-a)pyridiinien alkoksialkyylikarbamaatit
FI831437A7 (fi) 2-fenyyli-imidatso/4,5-c/pyridiinejä.
DE59009117D1 (de) [1,2,4] Triazolo [1,5-a]pyridine.
FI912376A7 (fi) Antivirala aemnen.
FI925053A7 (fi) Imidatso(4,5-c)pyridiinejä, joilla on PAF-antagonistinen aktiivisuus
FI903276A0 (fi) Cigarettstaenger med flytande flavoer i mitten.
DK0483052T3 (da) Picolinoxider
FI893605A7 (fi) Imidatso (4,5-b) pyridinderivat.
FI20000354L (fi) Perhydro-1H-pyrido/1,2-a/pyratsiinijohdannaiset
FI821035A0 (fi) Imidazo/1,2-a/pyrimidinderivat, deras framstaellning och anvaendning vid sjukvaord
FI864891A7 (fi) Foerfarande foer framstaellning av 6,7,8,9-tetrahydro-10-metylpyrido/1,2-a/indol-9-aminer och deras derivat.
IT8021821A0 (it) Pirido [1,2-a] pirimidine sostituite
FI906270A7 (fi) Imidatso/4,5-c/pyridiinit antiosteoporoottisina aineina
FI951996A7 (fi) 4-kinolinyylijohdannaiset, joilla on Helicobakteerin vastaista aktiivisuutta
FI870207A7 (fi) Foerfarande foer framstaellning av pyrrolo(1,2-a)(4,1)-bensoxazepiner.
FI941377A7 (fi) Neuroleptisiä 2-substituoituja perhydro-1-H-pyrido/1,2-a/-pyratsiineja
DE3267918D1 (de) Pyrazolo(3,4-b)pyridine derivatives
NO923489L (no) 1,4-dihydroksypyridiner med paf-antagonistisk aktivitet
DE3776199D1 (de) 2,3-dihydro-1-(8-methyl-1,2,4-triazolo(4,3-b)pyridazin-6-yl)-4(1h)-pyridinon.
DK122385D0 (da) 4,7-dihydropyrazolo(3,4-b)pyridinderivater

Legal Events

Date Code Title Description
FD Application lapsed